Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2026)
Hims & Hers Health (HIMS) reported Cash from Restructuring of $6.4 million for Q1 2026, up 518.16% on a YoY basis from $1.0 million in Q1 2025, and up 583.15% sequentially from $932000.0 in Q4 2025.
Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 4 years of Cash from Restructuring data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Restructuring rose 518.16% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (up 990.29% YoY), and the FY2025 full-year result was $5.9 million, changed N/A from the prior year.
- Cash from Restructuring grew to $6.4 million in Q1 2026, from $932000.0 in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $6.4 million in Q1 2026 to a low of -$256000.0 in Q3 2022.
- A 4-year average of $1.2 million and a median of $932000.0 in 2025 frame the typical range for Cash from Restructuring.
- Peak annual rise in Cash from Restructuring reached 4645.45% in 2023, while the deepest fall reached 58.74% in 2023.
- Tracing HIMS's Cash from Restructuring over 4 years: stood at $1.0 million in 2022, then plunged by 58.74% to $427000.0 in 2023, then jumped by 118.27% to $932000.0 in 2025, then soared by 583.15% to $6.4 million in 2026.
- Business Quant data shows HIMS's Cash from Restructuring at $6.4 million in Q1 2026, $932000.0 in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 932,000.00 |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 566,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | -256,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 69,000.00 |